Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Rating of “Hold” by Analysts

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company.

A number of brokerages recently weighed in on SAUHY. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Straumann in a research report on Tuesday, June 30th. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th. Barclays reissued an “overweight” rating on shares of Straumann in a research report on Thursday, June 18th. Citigroup restated a “sell” rating on shares of Straumann in a report on Thursday, July 9th. Finally, BMO Capital Markets started coverage on shares of Straumann in a research report on Wednesday, July 8th. They issued an “outperform” rating on the stock.

Straumann Stock Down 3.3%

Shares of OTCMKTS SAUHY opened at $12.54 on Friday. Straumann has a 12-month low of $9.44 and a 12-month high of $13.61. The stock’s fifty day simple moving average is $12.48 and its two-hundred day simple moving average is $11.69.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.